<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>THE &#34;NEW&#34;  PROSTATE CANCER INFOLINK</title>
	<atom:link href="http://talkaboutprostatecancer.wordpress.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://talkaboutprostatecancer.wordpress.com</link>
	<description></description>
	<lastBuildDate>Tue, 20 Dec 2011 14:24:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='talkaboutprostatecancer.wordpress.com' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title>THE &#34;NEW&#34;  PROSTATE CANCER INFOLINK</title>
		<link>http://talkaboutprostatecancer.wordpress.com</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://talkaboutprostatecancer.wordpress.com/osd.xml" title="THE &#34;NEW&#34;  PROSTATE CANCER INFOLINK" />
	<atom:link rel='hub' href='http://talkaboutprostatecancer.wordpress.com/?pushpress=hub'/>
		<item>
		<title>African-American men significantly underestimate their risk of a positive prostate biopsy</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/20/african-american-men-significantly-underestimate-their-risk-of-a-positive-prostate-biopsy/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/20/african-american-men-significantly-underestimate-their-risk-of-a-positive-prostate-biopsy/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 14:23:23 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[belief]]></category>
		<category><![CDATA[biopsy]]></category>
		<category><![CDATA[ethnicity]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[race]]></category>
		<category><![CDATA[risk]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14664</guid>
		<description><![CDATA[According to new data from a study at the University of Chicago, African-American males scheduled for a prostate biopsy are at greater risk for a positive diagnosis of cancer than white males and they also significantly underestimate their probability of a positive biopsy result. The new study by Hemmerich et al. was based on data [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14664&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/20/african-american-men-significantly-underestimate-their-risk-of-a-positive-prostate-biopsy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Nerve-sparing surgery and post-surgical sexual function: news from Kyoto</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/20/nerve-sparing-surgery-and-post-surgical-sexual-function-news-from-kyoto/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/20/nerve-sparing-surgery-and-post-surgical-sexual-function-news-from-kyoto/#comments</comments>
		<pubDate>Tue, 20 Dec 2011 13:13:41 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[nerve-sparing]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[radical prostatectomy]]></category>
		<category><![CDATA[sexual function]]></category>
		<category><![CDATA[surgery]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14658</guid>
		<description><![CDATA[According to a report from Prof. Thomas Aherling on the UroToday web site, there were three interesting presentations related to nerve-sparing surgery at the recent World Conference of Endourology and SWL, in Kyoto Japan. In the first of these presentations, Schatloff et al. presented data suggested that surgeons highly experienced in the conduct of robot-assisted [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14658&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/20/nerve-sparing-surgery-and-post-surgical-sexual-function-news-from-kyoto/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The USPSTF, communication, and the politics of cancer screening guidance</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/19/the-uspstf-communication-and-the-politics-of-cancer-screening-guidance/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/19/the-uspstf-communication-and-the-politics-of-cancer-screening-guidance/#comments</comments>
		<pubDate>Mon, 19 Dec 2011 13:56:28 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[USPSTF]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14656</guid>
		<description><![CDATA[Some readers may want to review the article on the Reuters web site entitled &#8220;Health panel takes heat on cancer screening advice.&#8221; In this article, not only do current and past members of the USPSTF appear to acknowledge that they could (and should) do a better job of how they communicate the recommendations that they [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14656&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/19/the-uspstf-communication-and-the-politics-of-cancer-screening-guidance/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>ACS rolls out new process for developing cancer guidelines</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/16/acs-rolls-out-new-process-for-developing-cancer-guidelines/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/16/acs-rolls-out-new-process-for-developing-cancer-guidelines/#comments</comments>
		<pubDate>Fri, 16 Dec 2011 13:55:14 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[American Cancer Society]]></category>
		<category><![CDATA[guidelines]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14653</guid>
		<description><![CDATA[Many organizations develop guidelines for the prevention, diagnosis, and treatment of cancer (prostate cancer included). And the differences between these guidelines can be striking and controversial &#8230; depending on who participates in the process of guideline development, who is writing them, how decisions are made, and who has additional input as expert third parties. The [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14653&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/16/acs-rolls-out-new-process-for-developing-cancer-guidelines/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>DoD CDMRP funding and prostate cancer research for FY 2012</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/#comments</comments>
		<pubDate>Fri, 16 Dec 2011 11:47:11 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[CDMRP]]></category>
		<category><![CDATA[research]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14649</guid>
		<description><![CDATA[It appears that research funding of $80 million will again be directed for use to study prostate cancer through the Department of Defense&#8217;s Congressionally Directed Medical Research Program (DoD CDMRP) for the financial year 2012. This is a big and important &#8220;win&#8221; for prostate cancer research during a time of fiscal constraint. Congratulations to all those advocates [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14649&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>PSA density and the estimation of risk for upgrading of localized prostate cancer</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/15/psa-density-and-the-estimation-of-risk-for-upgrading-of-localized-prostate-cacer/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/15/psa-density-and-the-estimation-of-risk-for-upgrading-of-localized-prostate-cacer/#comments</comments>
		<pubDate>Thu, 15 Dec 2011 19:54:24 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14615</guid>
		<description><![CDATA[An article published on-line in BJU International suggests that there are limits to the degree to which PSA density is accurately predictive of risk for upstaging of clinically localized prostate cancer. It is well understood that the biopsy-based Gleason score of a man with clinically localized prostate cancer can easily be underestimated &#8212; because of [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14615&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/15/psa-density-and-the-estimation-of-risk-for-upgrading-of-localized-prostate-cacer/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The patients&#8217; expectations and the doctors&#8217; dilemmas</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/#comments</comments>
		<pubDate>Thu, 15 Dec 2011 03:49:34 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[patient]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=14636</guid>
		<description><![CDATA[The following article was just published by Ranjana Srivastava, MD, in The New England Journal of Medicine under the title &#8220;Dealing with uncertainty in a time of plenty.&#8221; The &#8220;New&#8221; Prostate Cancer InfoLink does not normally condone or practice the reproduction of copyrighted material. However, the following article has already been widely distributed on the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14636&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Is mass prostate cancer screening even ethical in men ≥ 65 years of age?</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/14/is-mass-prostate-cancer-screening-even-ethical-in-men-%e2%89%a5-65-years-of-age/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/14/is-mass-prostate-cancer-screening-even-ethical-in-men-%e2%89%a5-65-years-of-age/#comments</comments>
		<pubDate>Thu, 15 Dec 2011 02:58:27 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[elderly]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[testing]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14620</guid>
		<description><![CDATA[Now here&#8217;s a new perspective on the value of widespread prostate cancer screening from one of the founders of Prostate Cancer Awareness Week &#8212; Dr. David Crawford of the University of Colorado Health Science Center in Denver, CO  (who is also the Chairman of the Prostate Conditions Education Council): The utility of screening and diagnosing [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14620&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/14/is-mass-prostate-cancer-screening-even-ethical-in-men-%e2%89%a5-65-years-of-age/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Cancer (and prostate cancer) screening in the elderly</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/13/cancer-and-prostate-cancer-screening-in-the-elderly/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/13/cancer-and-prostate-cancer-screening-in-the-elderly/#comments</comments>
		<pubDate>Tue, 13 Dec 2011 16:13:07 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[elderly]]></category>
		<category><![CDATA[recommendation]]></category>
		<category><![CDATA[screening]]></category>
		<category><![CDATA[testing]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14613</guid>
		<description><![CDATA[The value of regular testing of increasingly elderly men and women for risk of cancer is controversial. However, a new paper in the Archives of Internal Medicine has certainly added to our knowledge of just how widespread such testing may be &#8230; at least in the USA. Bellizzi et al. set out to estimate the prevalence [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14613&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/13/cancer-and-prostate-cancer-screening-in-the-elderly/feed/</wfw:commentRss>
		<slash:comments>8</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Regret post-treatment in men with pre-existing cardiovascular disease</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/10/regret-post-treatment-in-men-with-pre-existing-cardiovascular-disease/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/10/regret-post-treatment-in-men-with-pre-existing-cardiovascular-disease/#comments</comments>
		<pubDate>Sat, 10 Dec 2011 14:37:22 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[comorbidity]]></category>
		<category><![CDATA[localized]]></category>
		<category><![CDATA[regret]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14605</guid>
		<description><![CDATA[Another newly published paper, this time in the British Journal of Urology, addresses issues related to cardiovascular disease and the treatment of prostate cancer. However, in this case it is about the treatment of men who had an existing cardiovascular condition at the time of their initial treatment. In this paper, Nguyen et al. sought [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14605&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/10/regret-post-treatment-in-men-with-pre-existing-cardiovascular-disease/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>A new name for some forms of neoplastic prostate pathology?</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/09/a-new-name-for-some-forms-of-neoplastic-prostate-pathology/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/09/a-new-name-for-some-forms-of-neoplastic-prostate-pathology/#comments</comments>
		<pubDate>Sat, 10 Dec 2011 01:22:20 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA["prostatic epithelial neoplasia"]]></category>
		<category><![CDATA[low risk]]></category>
		<category><![CDATA[pathology]]></category>
		<category><![CDATA[PEN]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14603</guid>
		<description><![CDATA[The issue of whether to remove the &#8220;cancer&#8221; word from the diagnosis of at least some forms of prostate pathology that are not likely to lead to clinically significant disease over an extended period of time is not new. However, it came up yet again the the NIH state of the science conference in Bethesda [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14603&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/09/a-new-name-for-some-forms-of-neoplastic-prostate-pathology/feed/</wfw:commentRss>
		<slash:comments>7</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>What&#8217;s next on the active surveillance front?</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/08/whats-next-on-the-active-surveillance-front/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/08/whats-next-on-the-active-surveillance-front/#comments</comments>
		<pubDate>Thu, 08 Dec 2011 14:03:36 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[active surveillance]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14596</guid>
		<description><![CDATA[Here &#8212; for whatever they are worth &#8212; are some musings about what (in our opinion) seems to have come out of the NIH state of the science conference on active surveillance held earlier this week. As previously noted, the initial draft consensus statement from the panel discussants can be found on line if you [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14596&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/08/whats-next-on-the-active-surveillance-front/feed/</wfw:commentRss>
		<slash:comments>17</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Just what is the real risk (of cardiovascular morbidity and mortality for men on ADT)?</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/07/just-what-is-the-real-risk-of-cardiovascular-morbidity-and-mortality-for-men-on-adt/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/07/just-what-is-the-real-risk-of-cardiovascular-morbidity-and-mortality-for-men-on-adt/#comments</comments>
		<pubDate>Wed, 07 Dec 2011 16:26:02 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[ADT]]></category>
		<category><![CDATA[androgen deprivation therapy]]></category>
		<category><![CDATA[cardiovascular]]></category>
		<category><![CDATA[meta-analysis]]></category>
		<category><![CDATA[mortality]]></category>
		<category><![CDATA[risk]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14591</guid>
		<description><![CDATA[So a meta-analysis of data from multiple clinical trials has now shown rigorously something that we did, in fact, already know &#8230; that there was no excess incidence of cardiovascular mortality associated with androgen deprivation therapy (ADT) in clinical trials conducted to date in which use of ADT was compared to a placebo. The paper [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14591&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/07/just-what-is-the-real-risk-of-cardiovascular-morbidity-and-mortality-for-men-on-adt/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>NIH panel statement on active surveillance in prostate cancer</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/07/nih-panel-statement-on-active-surveillance-in-prostate-cancer/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/07/nih-panel-statement-on-active-surveillance-in-prostate-cancer/#comments</comments>
		<pubDate>Wed, 07 Dec 2011 12:41:36 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[active surveillance]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14587</guid>
		<description><![CDATA[The official, draft, state-of-the-science statement from the National Institutes of Health  conference on the role of active surveillance in the management of men with localized prostate cancer was made publicly available just a few minutes ago this morning.  To read the full statement, please click here. The &#8220;New&#8221; Prostate Cancer InfoLink has yet to read [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14587&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/07/nih-panel-statement-on-active-surveillance-in-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>12</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Active surveillance for localized prostate cancer: the state of the science</title>
		<link>http://talkaboutprostatecancer.wordpress.com/2011/12/05/active-surveillance-for-localized-prostate-cancer-the-state-of-the-science/</link>
		<comments>http://talkaboutprostatecancer.wordpress.com/2011/12/05/active-surveillance-for-localized-prostate-cancer-the-state-of-the-science/#comments</comments>
		<pubDate>Mon, 05 Dec 2011 13:28:43 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[active surveillance]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14584</guid>
		<description><![CDATA[So the National Institutes of Health (NIH) &#8220;state of the science&#8221; conference on the role of active surveillance in the management of men with localized prostate cancer starts this morning here at the NIH campus in Bethesda, MD. The panel is charged with delivering answers to five specific questions: How has the patient population and [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=talkaboutprostatecancer.wordpress.com&amp;blog=3176292&amp;post=14584&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://talkaboutprostatecancer.wordpress.com/2011/12/05/active-surveillance-for-localized-prostate-cancer-the-state-of-the-science/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
	</channel>
</rss>
